Page 103 - ITPS-7-1
P. 103

INNOSC Theranostics and
            Pharmacological Sciences                                               Plants immunoactivity: In silico study



            medication development, the majority of anti-kinase   the practical impacts of these lead compounds and their
            research  has  centered  on  protein  kinase  targets,  with  a   potential impact on immunomodulatory proteins against
            few significant exceptions. Manning  et al. reported that   multiple myeloma.
            the human genome encodes 518 distinct protein kinases,
            each facilitating the transfer of the gamma-phosphate   Acknowledgments
            group of ATP to the hydroxyl groups of proteins. These   None.
            protein kinases are categorized into two types based on
            the  phosphorylated amino  acids.  They  are  important   Funding
            components of biological signal transduction pathways that
            regulate cell proliferation, survival, and migration. While   None.
            numerous tyrosine kinases (TKs) reside in the cytosolic   Conflict of interest
            domains of plasma membrane receptors, multi-capability
            serine/threonine kinases (S/TKs) can also be located in the   The authors declare that they have no conflict of interest.
            plasma  membrane;  however,  the majority  is distributed
            throughout the cytosol and other cellular compartments.   Author contributions
            This observation aligns with the GO analysis of cellular   Conceptualization: Funmilayo I. D. Afolayan
            compartments (CC), which highlights the cytosol as the   Investigation: Deborah G. Joseph.
            most significantly enriched cellular compartment among   Writing – original draft: Joseph Deborah G.
                        [60]
            the gene targets .                                 Writing – review & editing: All authors
              However, this study has a few limitations. First, it relies   Ethics approval and consent to participate
            on the already identified chemical constituents from  W.
            somnifera and  A. barbadensis, potentially overlooking   Not applicable.
            the immunomodulatory effect of unknown chemical    Consent for publication
            constituents. In addition, although favorable binding
            affinities were observed between the hub targets and   Not applicable.
            corresponding phytoconstituents during the molecular
            docking simulation, further studies are necessary to   Availability of data
            authenticate and validate these interactions.      Supporting data can be obtained from the corresponding
            5. Conclusion                                      author following a formal request.

            The study’s approach leverages network pharmacology   References
            and molecular docking techniques to uncover active   1.   Yagi A, Yu BP, 2021, Immune modulation of  Aloe vera:
            phytocompounds and their potential mechanism of       Acemannan and gut microbiota modulator. J Gastroenterol
            immunomodulation. Network pharmacology analysis       Hepatol Res, 4: 1707–1721.
            revealed that HCK, PDPK1, and JAK2 are crucial     2.   Ayivi R, Ibrahim S, Colleran H,  et  al., 2021,
            immunomodulatory  targets for multiple  myeloma       COVID-19:  Human  immune  response  and the  influence
            treatment. These effects are achieved through the inhibition   of food ingredients and active compounds.  Bioactive
            of major signaling pathways that have been constitutively   Compounds Health Dis, 4: 100.
            activated, aligning with previous research. Notably, the
            study highlights significant pathways, including the PI3K-     https://doi.org/10.31989/bchd.v4i6.802
            Akt signaling pathway, NOD-like receptor signaling   3.   Newman DJ, Cragg GM, 2020, Natural products as sources
            pathway,  and TLR  signaling  pathways.  The molecular   of new drugs over the nearly four decades from 01/1981 to
            docking analysis further supports these results, suggesting   09/2019. J Nat Prod, 83: 770–803.
            that with anolide G, Somniferine, and Somniferanolide      https://doi.org/10.1021/acs.jnatprod.9b01285
            from W. somnifera hold potential as IMiDs leads targeting   4.   Tharakan  A,  Himanshu  S, Irin  RB,  et  al.,  2021,
            PDPK1, HCK, and JAK2 hub proteins in multiple         Immunomodulatory  effect  of  Withania  somnifera
            myeloma from the network pharmacology construction.   (Ashwagandha) Extract--a randomized, double-blind,
            These compounds exhibit promise in modulating key     placebo controlled trial with an open label extension on
            pathways in cancer, notably the PI3-AKT pathway, VEGFA   healthy participants. J Clin Med, 10: 3644.
            pathway,  JAK-STAT  signaling  pathway,  and  mTOR
            signaling pathway. Consequently, it is recommended that      https://doi.org/10.3390/jcm10163644
            further in vivo and in vitro studies be conducted to assess   5.   Afewerky HK, Ayodeji AE, Tiamiyu BB, et al., 2021, Critical


            Volume 7 Issue 1 (2024)                         14                        https://doi.org/10.36922/itps.1076
   98   99   100   101   102   103   104   105   106   107   108